Citation Impact
Citing Papers
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Pharmacokinetics, Tolerability, and Fructosamine-Lowering Effect of a Novel, Controlled-Release Formulation of α-Lipoic Acid
2002
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Inflammation and metabolic disorders
2006 StandoutNature
Accelerated degradation of mislocalized UDP–glucuronosyltransferase family 1 (UGT1) proteins in Gunn rat hepatocytes
2002 StandoutNobel
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The metabolic syndrome
2010 Standout
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
The pharmacology of the antioxidant lipoic acid
1997 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Microglial cell origin and phenotypes in health and disease
2011 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
R-α-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes
2002
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Mechanisms of obesity-associated insulin resistance: many choices on the menu
2007
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non‐alcoholic fatty liver disease
2006
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Nitric Oxide Dysfunction in the Pathophysiology of Preeclampsia
2000
The metabolic syndrome
2005 Standout
Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
2014
The role of vitamin E and oxidative stress in diabetes complications
2010
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
α-Lipoic Acid in Liver Metabolism and Disease
1998
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance
2008 Standout
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate
2012
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress
2003
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
2014
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
The Discovery and Development of Liraglutide and Semaglutide
2019
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
2001 Standout
Molecular aspects of lipoic acid in the prevention of diabetes complications
2001
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
2009
Adipose Tissue as an Endocrine Organ
2004 Standout
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
Proposed Mechanisms for the Induction of Insulin Resistance by Oxidative Stress
2005
α-Lipoic Acid: A Multifunctional Antioxidant That Improves Insulin Sensitivity in Patients with Type 2 Diabetes
2000
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
2009
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
2010
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice
2008 Standout
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials
2016
Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal‐F1)
2013
The Antihyperglycemic Drug α-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation
2001
A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP ‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients
2016
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
2003
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
2001
The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds
2004 Standout
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin
2013
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
2016
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Are Oxidative Stress−Activated Signaling Pathways Mediators of Insulin Resistance and β-Cell Dysfunction?
2003
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
Protection Against Oxidative Stress—Induced Insulin Resistance in Rat L6 Muscle Cells by Micromolar Concentrations of α-Lipoic Acid
2001
Endothelial Function and Dysfunction
2007 Standout
Works of Peter Ruus being referenced
Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia
2013
Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
1999
Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers
1998
Retigabine N-Glucuronidation and Its Potential Role in Enterohepatic Circulation
1999
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
2013
Effects of age and sex on the disposition of retigabine
2003
Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers
1996